Target lesion failure with biodegradable polymer sirolimus-eluting stents ( @ cases ; @ % ) was non-inferior to durable polymer everolimus-eluting stents ( @ cases ; @ % ) at @ months ( absolute risk difference -@ % , upper limit of one-sided @ % CI @ % , p for non-inferiority < @ ) .